Company news

Curis, Inc. news in 2023

Curis, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study

December 11, 2023

Curis Announces Three Presentations at ASH

December 5, 2023

Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

December 4, 2023

Curis Provides Third Quarter 2023 Business Update

November 1, 2023

Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023

October 25, 2023

Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer

September 11, 2023

Curis Provides Second Quarter 2023 Business Update

August 2, 2023

Curis to Release Second Quarter 2023 Financial Results and Hold Conference Call on August 3, 2023

July 26, 2023

Curis Announces $15.1 Million Registered Direct Offering

July 5, 2023

Curis Provides First Quarter 2023 Business Update

May 3, 2023

Curis Reschedules Fourth Quarter 2022 Business Update and Conference Call

March 7, 2023

Curis to Release Fourth Quarter 2022 Financial Results and Hold Conference Call on March 9, 2023

March 1, 2023

Calls in 2023

Decks in 2023